Akoya Biosciences logo

Akoya Biosciences Funding & Investors

Akoya Biosciences, Inc. operates as a biotechnology company. The Company offers end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. Akoya Biosciences serves customers worldwide.

akoyabio.com

Total Amount Raised: $127,000,000

Akoya Biosciences Funding Rounds

  • Post Ipo Equity

    $43,500,000

  • Series D

    $50,000,000

    Series D Investors

    Thomas Schnettler
    Piper Jaffray
    Innovatus Capital Partners
    Telegraph Hill Partners
  • Series Unknown

    $24,500,000

    Series Unknown Investors

    Telegraph Hill Partners
  • Series Unknown

    $9,000,000

    Series Unknown Investors

    Telegraph Hill Partners
Funding info provided by Diffbot.